| Diane K Hoese, CNS | |
|
1805 Ford Ave N, Mcleod Cty Public Health, Suite 200, Glencoe, MN 55336-1363 | |
| (320) 864-3185 | |
| (320) 864-1484 |
| Full Name | Diane K Hoese |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Adult Health |
| Location | 1805 Ford Ave N, Glencoe, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649415993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2200X | Clinical Nurse Specialist - Adult Health | R0785150 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Diane K Hoese, CNS 1805 Ford Ave N, Mcleod Cty Public Health, Suite 200, Glencoe, MN 55336-1363 Ph: (320) 864-3185 | Diane K Hoese, CNS 1805 Ford Ave N, Mcleod Cty Public Health, Suite 200, Glencoe, MN 55336-1363 Ph: (320) 864-3185 |
News Archive
Before the 1960's knowledge of the intrauterine environment was like a black box, limiting clinical understanding, and monitoring of the fetus during pregnancy. Little was known about the fetus until after birth happened. Now that has changed dramatically, and there have been revolutionary advances, particularly in the last 20 years enabling clinicians to diagnose and treat problems which develop in the womb.
Researchers at Binghamton University, State University of New York have devised a new way to protect personal electronic health records using a patient's own heartbeat.
Media registration is now open online for TCT 2013 (Transcatheter Cardiovascular Therapeutics), the annual Scientific Symposium of the Cardiovascular Research Foundation. Celebrating its 25th anniversary this year, the theme of TCT 2013 is envisioning the future, with a focus on innovation in medicine and technology.
The German Federal Institute for Drugs and Medical Devices (BfArM) has granted Moberg Derma approval to initiate a clinical phase II trial for Limtop. The aim is to evaluate the efficacy and safety of three different dose regimens of Limtop in a study involving 96 patients with Actinic Keratosis (AK) on the head or face.
Children who regularly see specialists for chronic medical conditions are also using complementary medicine at a high rate, demonstrates recently published research from the University of Alberta and the University of Ottawa.
› Verified 3 days ago